Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?

计划入组 180 人 · 首次发布于 2016 年 7 月 26 日

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

计划入组 115 人 · 首次发布于 2024 年 7 月 1 日

Biomarkers Associated With Postoperative Cognitive Dysfunction

计划入组 45 人 · 首次发布于 2022 年 7 月 19 日

ZPF (Sangamo)

11C-TAU-7

TAU-2023

Alpha Tau Medical

Israel

Sigma Tau I.f.r S.p.a.

SIGMA-TAU RESEARCH INC

United States

Nicotinamide Fails to Show Clear Benefit in Reducing Tau Proteins in Early Alzheimer's Trial

Alamar Biosciences Revolutionizes Alzheimer's Detection with Blood-Based Brain-Derived Tau Assays

Roche and Lilly's Alzheimer's Blood Test Receives FDA Breakthrough Device Designation